Literature DB >> 11260184

Leukaemia inhibitory factor and interleukin-8 expression in nonmelanoma skin cancers.

J C Szepietowski1, C Walker, D B McKenna, J A Hunter, R C McKenzie.   

Abstract

Leukaemia inhibitory factor (LIF) and interleukin (IL)-8 possess activities which may contribute to the development of carcinomas. LIF can stimulate proliferation of some tumour cell lines and IL-8 is angiogenic. Using semiquantitative reverse-transcription polymerase chain reaction (RT-PCR), we measured the expression of LIF and IL-8 mRNA in cultured normal keratinocytes (NKC) and the malignant carcinoma cells lines A431, SiHa, HeLa, and in biopsies of basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and normal skin. Protein expression for LIF was assessed by immunohistochemistry in the biopsies. LIF mRNA expression was increased significantly (P < 0.01) in all carcinoma lines, except SiHa, compared with NKC but the IL-8 mRNA expression in carcinoma cell lines was similar to that in NKC. Expression of LIF mRNA was elevated in BCC and SCC compared with normal skin, but a significant difference was observed only between SCC and normal skin (P < 0.01). Both BCC and SCC showed significantly greater expression of IL-8 compared with normal skin (P < 0.01). There was no correlation between LIF and IL-8 mRNA expression either in BCCs or in SCCs. Immunoreactivity for LIF was absent throughout BCC and SCC, however, normal epidermis surrounding the tumour stained positive, as in normal skin. These data may suggest a role for LIF and IL-8 in the development of skin carcinomas, but without co-ordinate regulation of these two cytokines in this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260184     DOI: 10.1046/j.1365-2230.2001.00765.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours.

Authors:  Noemi Moubayed; Michael Weichenthal; Jürgen Harder; Elke Wandel; Michael Sticherling; Regine Gläser
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-29       Impact factor: 4.553

2.  Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.

Authors:  Tasneem Kausar; Rinu Sharma; Md Raghibul Hasan; Anoop Saraya; Tushar K Chattopadhyay; Siddartha Datta Gupta; Ranju Ralhan
Journal:  Cell Oncol (Dordr)       Date:  2011-03-11       Impact factor: 6.730

3.  Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia.

Authors:  M Zak-Prelich; R C McKenzie; A Sysa-Jedrzejowska; M Norval
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

4.  STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland.

Authors:  Martyna Sławińska; Monika Zabłotna; Jolanta Gleń; Joanna Lakomy; Roman J Nowicki; Michał Sobjanek
Journal:  Arch Dermatol Res       Date:  2019-07-24       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.